Arthneeti
All Q2 FY26 results →
CC

Centene Corporation

Q2 FY26Health Care Providers and Services

Centene Corporation Q2 FY26 Results — Earnings Call Analysis

Q2 FY26 earnings call: what management said on revenue, margins and capex.

Price₹59
Market cap₹29.1K Cr
P/E12.8
Updated29 May 2026
Read3 min read

What the Q2 FY26 call signalled

1 of 2 strong

MarginMargins steady
FundraiseFundraise planned

The short version

- Medicaid membership expected to decrease about 6% year-over-year but with a composite rate yield around 4.5%, indicating revenue growth from rate adjustments. - Centene increased its full-year 2026 adjusted EPS guidance to greater than $3.40, up from the previous expectation of greater than $3.00, reflecting strong Q1 performance.

From Centene Corporation's Q2 FY26 earnings-call transcript · updated 29 May 2026.

Revenue & Sales Performance

  • Medicaid membership expected to decrease about 6% year-over-year but with a composite rate yield around 4.5%, indicating revenue growth from rate adjustments.
  • Marketplace membership projected to slightly decline from 3.58 million to just over 3 million by year-end 2026, but with improved risk adjustment benefits leading to better margins.
  • Medicare segment, including Medicare Advantage and Part D PDP, shows strong momentum with expectations of continued outperformance and margin improvement into 2027.
  • Specialty pharmacy and high-cost drug trends are high but managed actively, with bids and forecasts calibrated accordingly, supporting sustained revenue.

2 more points from Centene Corporation's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Centene Corporation said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Some relevant points related to investments and strategic focus include: - Continued scaling and strengthening of multi-pronged trend management programs across Medicaid and Medicare. - Investments in data-driven network optimization to ensure access to high-performing providers. - Deployment of innovative total cost of care models targeting high-cost specialties (oncology, chronic kidney disease, behavioral health). - Focus on building a disciplined, performance-driven value-based care model integrated with network strategy and clinical execution. - Ongoing development and application of AI for fraud, waste, and abuse detection across multiple states.

2 more points from Centene Corporation's call on capex

Create a free account to keep reading this call

Fundraising & Capital Structure

See what Centene Corporation said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

See what Centene Corporation said on order book & pipeline — free account, 30 seconds.

Continue your research

Others in Health Care Providers and Services this season

  • BrightSpring Health Services, Inc. (Q2 FY26)

    BrightSpring Health Services, Inc. Q2 FY26 quarterly results analysis. Pharmacy Solutions expected to see balanced sequential revenue and EBITDA growth througho

  • DaVita Inc. (Q2 FY26)

    DaVita Inc. Q2 FY26 quarterly results analysis. Treatment volume guidance raised from flat to 25-50 basis points growth for 2026, driven by better underlying pe

  • Tenet Healthcare Corporation (Q2 FY26)

    Tenet Healthcare Corporation Q2 FY26 quarterly results analysis. Hospital segment expects a 10% normalized year-over-year adjusted EBITDA growth in 2026, suppor

  • Guardant Health, Inc. (Q2 FY26)

    Guardant Health, Inc. Q2 FY26 quarterly results analysis. Sales team started this year with ~300 reps; incremental gross profit will be reinvested in expanding

Compare:vs UnitedHealth Group Incorporatedvs McKesson Corporationvs Elevance Health, Inc.

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Centene Corporation and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Centene Corporation Q2 FY26 results?

- Medicaid membership expected to decrease about 6% year-over-year but with a composite rate yield around 4.5%, indicating revenue growth from rate adjustments. - Centene increased its full-year 2026 adjusted EPS guidance to greater than $3.40, up from the previous expectation of greater than $3.00, reflecting strong Q1 performance.

What is Centene Corporation share price analysis?

Centene Corporation currently shows a neutral. The stock trades at a P/E of 12.8 with a market cap of $29,090. Investors should review the full earnings analysis for detailed insights.

Keep Centene Corporation on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.